About the Authors
- Atle Fretheim, Morten Aaserud, Andrew D Oxman
- Norwegian Knowledge Centre for Health Services, Oslo, Norway
AF and ADO were responsible for the RaPP trial, which was an evaluation of the intervention in question. MA has previously carried out short-term pharmacoeconomic projects for the National Insurance Service and the Norwegian Medicines Agency. From 1997 to 1999 MA worked for a private company, Brevreklame, doing market research for pharmaceutical firms in Norway.
AF and ADO designed the study, with support from MA. AF and MA analyzed the data, with support from ADO. AF wrote the first draft, which was developed further through discussion and input from MA and ADO. All authors contributed to and approved the final manuscript.